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Abstract
Background: Gestational diabetes mellitus (GDM), defined as any degree of glucose intolerance with onset during
pregnancy, is increasing worldwide, mostly because obesity among women of reproductive age is continuously
escalating. GDM is associated with adverse maternal and fetal outcomes. The aim of this article was to systematically
review literature on the effectiveness of nutritional factors before or during pregnancy to prevent GDM.
Methods: We assessed the primary prevention of GDM through nutritional factors, as diet and supplements. We
searched on PubMed, Cochrane Databases and ClinicalTrials.gov from inception to June 2016. Clinical trials and
adjusted prospective cohort studies were included.
Results: Eight clinical trials and twenty observational studies assessing the association between dietary factors and
primary prevention of GDM were included. Furthermore, six clinical trials and two observational studies related to
supplements were also added. Only two nutritional interventions were found to significantly reduce the incidence of
GDM, besides the supplements. However, the observational studies showed that a higher adherence to a healthier
dietary pattern can prevent the incidence of GDM, especially in high risk population before getting pregnant.
Conclusions: The results indicate that there may be some benefits of some nutritional factors to prevent GDM.
However, better-designed studies are required to generate higher quality evidence. At the moment, no strong
conclusions can be drawn with regard to the best intervention for the prevention of GDM.
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Background
Gestational diabetes mellitus (GDM), defined as any
degree of glucose intolerance with onset during preg-
nancy, is increasing worldwide. In fact, prevalence has
increased by 10–100% in the last 20 years [1]. More
mothers entering pregnancy as obese and of advanced
maternal age has contributed to the escalation of GDM
cases. Several risk factors are known for GDM; advanced
maternal age, obesity, physical inactivity, parity, ethnicity,
family history of type type 2 diabetes (T2D), history of
macrosomic babies, and a previous history of GDM [2, 3].
GDM is associated with adverse maternal and fetal
outcomes during pregnancy and long term health [4].
In order to prevent these adverse outcomes, such as
T2D, it is imperative to understand the hormonal changes
and altered glucose metabolism that are associated with
the development of GDM during pregnancy [5]. GDM
occurs when insulin receptors are not able to respond
adequately to control blood sugar levels due to hor-
mones produced in pregnancy, such as human placental
lactogen, which impacts susceptible insulin receptors.
This in turn causes inappropriately high levels of blood
sugar. Due to the similarities in the underlying patho-
physiology and risk factors of GDM and T2D, it is
probable that the factors that are effective in the pre-
vention of T2D may be successful in the prevention of
GDM as well. These factors include dietary pattern,
physical activity, a decrease in rates of obesity and ges-
tational weight gain. It is important to identify popula-
tion factors to reduce the increasing rates of GDM as it
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is doing for T2D. The aim of the researchers was to
systematically review literature on clinical trials and
prospective cohort studies focusing on the effectiveness
of nutritional factors (diet and supplements) before or
during pregnancy to prevent GDM.
The study protocol is available as a supplementary file
in this article.
Methods
We undertook this systematic review following a protocol
in accordance with the current recommendations of
PRISMA and MOOSE guidelines [6, 7].
No ethical approval is required for this research
project.
Search strategy
Articles were researched in the following databases:
PubMed, Cochrane Databases and ClinicalTrials.gov
from inception to June 2016. The keywords used for the
search were: “gestational diabetes”, “diet” and “nutrition”.
Another search was done for the keywords of “supple-
ment” and “gestational diabetes”. The search strategy
was done independently by two researchers, and both
extracted the relevant studies to be included in this sys-
tematic review. The disagreement between the researchers
was resolved consulting a third researcher in order to
reach an accord. We restricted publications to English,
French and Spanish languages. All the researchers have an
advanced level in these three languages. The selection
process of the articles began from reading the titles. After
this initial phase, the selected papers were reviewed by
reading their abstracts. At that time, these selected studies
were separated for further analysis to identify relevant
publications, according to the inclusion/exclusion criteria.
For the selection of studies, inclusion criteria were
adopted such as: clinical trials or adjusted prospective
cohort studies, originals, and primary prevention of
GDM through nutritional factors. Due to inherent limi-
tations other epidemiological studies were excluded.
Exclusion criteria were: presence of diabetes mellitus
type 1 or 2 prior to pregnancy, presence of diseases
prior to pregnancy requiring dietary treatment, evaluation
of diet as a treatment for patients with GDM, only
physical activity for prevention of GDM and research
on animals. Additional articles were identified from the
reference lists of relevant studies and reviews.
Results and discussion
Study selection
Our initial research in the aforementioned electronic data-
bases produced 1992 citations. Eighty-five articles were
identified as potential articles for further full text review.
After the next exclusion process, 28 articles were included
and another seven were added from reference lists.
The most important reason for exclusion was that diet
or supplements were evaluated as a treatment for
GDM, not as a primary prevention. We identified a
total of 35 relevant articles (Fig. 1. Legend; Flow-chart
of prospective cohort studies and clinical trials in-
cluded in the systematic review. The search used the
following combinations of terms: “diet” or “nutrition”
and “gestational diabetes mellitus”. A second search was
done with the terms “supplement” and “gestational dia-
betes mellitus”. Filters; Human; languages: English,
French and Spanish; date: up to June 30, 2016).
Twenty-eight were related to diet and primary preven-
tion of GDM, eight were clinical trials (Additional file 1:
Table S1) and 20 were prospective cohort studies
(Additional file 2: Table S2). There were eight articles
related to supplements and primary prevention of GDM,
six clinical trials (Additional file 3: Table S3) and two
prospective cohort studies (Additional file 4: Table S4).
Lastly, there was one article [8] that studied whether
dietary and supplemental iron were related to the occur-
rence of GDM (Additional file 2: Tables S2 and Additional
file 4: Table S4).
Quality of the included studies
Of the 14 clinical trials included, only one was not ran-
domized [9]. All women were pregnant when intervention
had begun in the clinical trials. The diagnosis of GDM
was based on the Oral Glucose Tolerance Test (OGTT),
although the measurements of the OGTT was not the
same in all articles, some considered the fasting glucose
level abnormal when ≥ 5.3 mmol/l [9–11], but others
consider it to be abnormal when ≥ 4.8 mmol/l [12],
≥5.1 mmol/l [13, 14] or ≥5.5 mmol/l [15]. Furthermore,
the glucose level readings at 1 h and at 2 h were also
1992 citations identified from electronic 
databases (inception to June 2016)
85 potentially relevant articles identified 
for further full text review
28 studies included in the systematic 
review
1907 citations excluded based on 
screening of titles or abstract 
57 articles excluded because did 
not meet the inclusion criteria
Total of 35 articles* included in the 
systematic review:
-28 diet (8 clinical trials and 20 
prospective cohort studies)
-8 supplements (6 clinical trials and 2 
prospective cohort studies)
*1 article studied dietary factors and 
supplements
7 articles identified through other 
sources (hand-search references)
Fig. 1 Flow-chart of prospective cohort studies and clinical trials
included in the systematic review
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different. One article studied GDM incidence as a sec-
ondary outcome [16] and another one does not give a def-
inition of GDM, although they studied glucose blood
levels during the pregnancy of the participants [17].
The observational studies were adjusted for the most
important variables (such as age, parity, tobacco products,
BMI, physical activity, family history of diabetes, alcohol,
ethnicity, total calories consumed). Twelve of these arti-
cles [8, 18–28] were based on the Nurses’ Health Study II
cohort, which includes more than 13,000 women who
reported a singleton pregnancy. In this cohort, GDM
cases were identified through self-reported information.
The principal measures estimated in these studies were
Risk Ratios (RR) and differences in means of GDM
incidence.
Main findings
On one hand, no diet intervention was found to signifi-
cantly reduce the incidence of GDM except for the
intervention of the non-randomized controlled prag-
matic trial [11] and the intervention on lifestyle (including
diet) of Koivusalo et al. [10], (see Additional file 1:
Table S1). Wolff et al. [17] found that an intensive inter-
vention reduces the deterioration of glucose metabolism
in obese pregnant women, though they did not report any
incidence of GDM. Only two supplement interventions
with probiotics and myo-inositol during pregnancy
showed a decrease in the rates of GDM compared with a
placebo. Luoto et al. [12] intervention showed that probio-
tics (Lactobacillus Rhamnosus GG and Bifidobacterium
Lactis Bb12) reduced the incidence of GDM; 13% (diet/
probiotics) versus 36% (diet/placebo) and 34% (control),
p = 0.003. Luoto et al. [12] explain in their article that
probiotic consumption may protect against GDM because
these microorganisms can modify intestinal microbiota,
altering the fermentation of dietary polysaccharides and
improving intestinal barrier function. They also men-
tioned the importance of the capability of probiotics to
regulate the inflammatory pathways. It is understandable
that the protection against GDM provided by probiotics,
could be mediated through immunomodulatory pathways
and polysaccharide fermentation. Moreover, myo-inositol
supplements were found to reduce the incidence of GDM
in pregnant women (Matarrelli et al. [14]: RR = 0.127;
95% CI, 0.032–0.502; p = 0.001 and D’Anna et al. [13]:
OR = 0.34; 95% CI, 0.17–0.68; p = 0.001) and appear to
be an insulin sensitizer. It was reported to reduce plasma
glucose levels in insulin resistant conditions such as poly-
cystic ovary syndrome and during the third trimester of
GDM pregnancies [29]. The subjacent mechanism of
myo-inositol on metabolic benefits is not defined at the
moment. It may produce an intracellular effect directly on
the activation of acetil CoA carboxylase stimulating
lipogenesis. Another theory says that it is a precursor of
D-chiro-inositol, which contains inositol phosphoglycan
in the extracellular matrix of the cells. It has been pro-
posed that the binding of insulin to specific receptors
stimulates D-chiro-inositol, facilitating the transport to
the inside of the cell [30]. This explains how myo-inositol
interacts in the insulin-signaling cascade [31].
On the other hand, the observational studies collected
in Table S2 (Additional file 2) showed that achieving a
healthier dietary pattern [25], such a Mediterranean
dietary pattern, and lowering the intake of foods with
high heme iron content, sugar sweetened cola, potatoes,
fatty foods and sweets, can reduce the incidence of GDM,
especially among the high-risk population and before
getting pregnant [8, 21–23, 32–34].
Known evidence indicates that women who develop
GDM have altered functions of β-cells and insulin re-
sistance, limiting their capacity to cope with the metabolic
challenges of pregnancy [35]. Similarly, it is known that
iron is a redox-active transitional metal, a strong pro-
oxidant which promotes the creation of hydroxyl radicals,
increasing oxidative stress. The pancreatic β-cell is par-
ticularly sensitive to this type of stress due to weak anti-
oxidant protection [36]. Nevertheless, adherence to
healthy diets, such as the Mediterranean one, may reduce
GDM risk by minimizing such susceptibilities before preg-
nancy. Common components of these dietary patterns
include fruits and vegetables, relatively small amounts
of red and processed meats, and high quality carbohy-
drates. Fruits and vegetables in particular have many
antioxidant properties, in addition to providing fiber
and micronutrients such as magnesium and vitamin C.
The combination of all these factors may protect
against metabolic deterioration counteracting free radicals
and improving systemic oxidative stress [37].
Limitations
It is possible that a publication bias may have occurred
as there is a limited amount of publications related to
the study of primary intervention of GDM through diet,
and absorption of supplements, probiotics and other
minerals. In addition, the researchers are not discounting
the existence of other articles in databases that were not
used for this study.
Clinical applications
In this systematic review we found that the majority of
the interventions done during pregnancy are not effective
in preventing GDM, and although there were cases where
supplements proved to be beneficial, the evidence is very
scarce. However, dietary patterns prior to pregnancy seem
to reduce the risk of GDM. Programs encouraging young
women to achieve a healthy dietary pattern before getting
pregnant seem to be the best way to prevent GDM. Mea-
sures adopted during pregnancy seem to be ineffective
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because they require more time to properly curb the
development of GDM, especially among the high-risk
population.
Implications for future research
There is a strong need for additional research on this
topic. Although some prospective cohort studies have
found an association between some nutrients or dietary
patterns and the incidence of GDM, the existence of
consistency of the results in other populations should be
very desirable to prove causal associations between nutri-
tional factors and the risk of GDM. We did not find any
controlled trial that evaluated the intervention in dietary
pattern before patients get pregnant and the incidence of
GDM. Nevertheless, there is an ongoing European
multicenter randomized controlled trial in overweight
and obese pregnant women on lifestyle intervention
and/or vitamin D supplementation [38]. Researchers
have recently published the results of the pilot study
finding that a healthy eating has a preventive impact
on the risk of GDM [39]. Final results of the trial will
be published in the near future.
Conclusions
Overall, since there is evidence that some dietary pat-
terns, such as the Mediterranean diet, seem to lower the
risk of developing GDM, and since it has also been
shown to prevent other diseases (T2D, metabolic syn-
drome, cardiovascular diseases), the advice to adhere to
this type of dietary pattern could be the best way at
present to prevent GDM. Furthermore, it can be a good
way to prevent other pregnancy related diseases, such
as, hypertension and growth restriction. However, better
designed prospective and intervention studies, providing
high-quality data are required before conclusions can
be drawn about the best intervention for the prevention
of GDM.
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